Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma | Synapse
March 3, 2026Open Access
Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma
Key Points
TOP2A serves as a promising prognostic biomarker for lung adenocarcinoma, highlighting its relevance in patient outcomes.
A correlation between TOP2A expression and disease progression highlights its potential role in treatment decisions.
Analysis of RNA and protein expression discordance indicates the significance of TOP2A in targeting therapeutic strategies.
Identifying TOP2A as a target may enable better management of lung adenocarcinoma, increasing survival prospects.